HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data

Background/Aims: Quantification of the hepatitis B surface antigen (HBsAg) is increasingly used to determine the treatment response in patients with chronic hepatitis B (CHB). However, there are limited data about the clinical implications of Quantification of HBsAg long-term nucleoside analogue tre...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical and molecular hepatology 2013-12, Vol.19 (4), p.409
Hauptverfasser:	Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Format:	Artikel
Sprache:	kor
Schlagworte:	Chronic hepatitis B Entecavir HBsAg Lamivudine Resistance
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!